[HTML][HTML] Therapeutic advances in COVID-19
N Murakami, R Hayden, T Hills, H Al-Samkari… - Nature Reviews …, 2023 - nature.com
Over 2 years have passed since the start of the COVID-19 pandemic, which has claimed
millions of lives. Unlike the early days of the pandemic, when management decisions were …
millions of lives. Unlike the early days of the pandemic, when management decisions were …
Reviewing Interventions to Address Misinformation: The Need to Expand Our Vision Beyond an Individualistic Focus
Prior work has identified a variety of factors that drive the way people identify and respond to
misinformation. Such factors include confirmation bias, perceived credibility of the …
misinformation. Such factors include confirmation bias, perceived credibility of the …
Cost-effectiveness thresholds used by study authors, 1990-2021
PJ Neumann, DD Kim - Jama, 2023 - jamanetwork.com
The bars represent the distribution of ratings on a Likert scale (1= greatly favors preprint
abstract; 5= greatly favors published abstract) for the blinded comparison of the preprint and …
abstract; 5= greatly favors published abstract) for the blinded comparison of the preprint and …
Completeness and spin of medRxiv preprint and associated published abstracts of COVID-19 randomized clinical trials
H Spungen, J Burton, S Schenkel, DL Schriger - JAMA, 2023 - jamanetwork.com
Methods| We identified all COVID-19–related RCT preprints posted to medRxiv between
January 1, 2020, and December 31, 2021. On June 1, 2022, and November 15, 2022, title …
January 1, 2020, and December 31, 2021. On June 1, 2022, and November 15, 2022, title …
Structural growth of zinc oxide nanograins on carbon cloth as flexible electrochemical platform for hydroxychloroquine detection
Pharmaceutical pollution that imposes a health threat worldwide is making accurate and
rapid detection crucial to prevent adverse effects. Herein, binder-free zinc oxide nanograins …
rapid detection crucial to prevent adverse effects. Herein, binder-free zinc oxide nanograins …
[HTML][HTML] COVID-19 therapeutic potential of natural products
Despite the fact that coronavirus disease 2019 (COVID-19) treatment and management are
now considerably regulated, severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
now considerably regulated, severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
The potential role of SARS‐CoV‐2 infection in acute coronary syndrome and type 2 myocardial infarction (T2MI): Intertwining spread
AA Alsaidan, HM Al‐Kuraishy… - Immunity …, 2023 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is a novel pandemic caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). It has been shown that SARS …
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). It has been shown that SARS …
[HTML][HTML] Drug repositioning in the COVID-19 pandemic: Fundamentals, synthetic routes, and overview of clinical studies
ES Vaz, SV Vassiliades, J Giarolla, MC Polli… - European Journal of …, 2023 - Springer
Introduction Drug repositioning is a strategy to identify a new therapeutic indication for
molecules that have been approved for other conditions, aiming to speed up the traditional …
molecules that have been approved for other conditions, aiming to speed up the traditional …
[HTML][HTML] The potential of nanobodies for COVID-19 diagnostics and therapeutics
DB Naidoo, AA Chuturgoon - Molecular Diagnosis & Therapy, 2023 - Springer
The infectious severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the
causative agent for coronavirus disease 2019 (COVID-19). Globally, there have been …
causative agent for coronavirus disease 2019 (COVID-19). Globally, there have been …
[HTML][HTML] Host cell targets for unconventional antivirals against RNA viruses
VC Roa-Linares, M Escudero-Flórez… - Viruses, 2023 - mdpi.com
The recent COVID-19 crisis has highlighted the importance of RNA-based viruses. The most
prominent members of this group are SARS-CoV-2 (coronavirus), HIV (human …
prominent members of this group are SARS-CoV-2 (coronavirus), HIV (human …